Regression of cyclosporia-induced gingival overgrowth upon interruption of drug therapy

General Dentistry

Volumn 51, Issue 2, 2003, Pages 159-162

  Mathur, Hiru ^a   Moretti, Antonio J ^a   Flaitz, Catherine M ^b,c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Amer Bd Oral Maxillofacial Pathol ^*  (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; FUROSEMIDE; LABETALOL; NIFEDIPINE; PREDNISONE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; FEMALE; GINGIVA OVERGROWTH; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PATIENT CARE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; CHEMICALLY INDUCED DISORDER; GRAFT REJECTION; MIDDLE AGED; REMISSION; RENAL REPLACEMENT THERAPY;

CYCLOSPORINE; FEMALE; GINGIVAL OVERGROWTH; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; REMISSION INDUCTION; RENAL DIALYSIS;

EID: 2142658792     PISSN: 03636771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Calne RY, Pentlow BD, White DJ, Thiru S, Evans DB, McMaster P, Rolles K, Dunn DC, Craddock GN. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 1978;1:1323-1327.
2. Calne RY, Rolles K, White DJ, Thiru S, Evans DB, Henderson R, Hamilton DL, Boone N, McMaster P, Gibby O, Williams R. Cyclosporin-A in clinical organ grafting. Transplant Proc 1981;13:349-358.
3. Wysocki GP, Gretzinger HA, Laupacis A, Ulan RA, Stiller CR. Fibrous hyperplasia of the gingiva: A side effect of cyclosporin A therapy. Oral Surg Oral Med Oral Pathol 1983;55:274-278.
4. McGaw T, Porter H. Cyclosporine-induced gingival overgrowth: An ultrastructural stereologic study. Oral Surg Oral Med Oral Pathol 1988;65:186-190.
5. Rostock MH, Fry HR, Turner JE. Severe gingival overgrowth associated with cyclosporine therapy. J Periodontol 1986;57:294-299.
6. Seymour RA, Smith DG, Rogers SR. The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. A longitudinal study. J Clin Periodontol 1987;14:610-613.
7. Seymour, RA, Smith DG. The effect of a plaque control program on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 1991;18:107-116.
8. Thomas DW, Newcombe RG, Osborne GR. Risk factors in the development of cyclosporine-induced gingival overgrowth. Transplantation 2000;69:522-526.
9. O'Leary TJ, Drake RB, Naylor JE. The plaque control record. J Periodontol 1972;43:38.
10. Tyldesley WR, Rotter E. Gingival hyperplasia induced by cyclosporin-A. Br Dent J 1984;157:305-309.
11. King GN, Healy CM, Glover MT, Kwan JT, Williams DM, Leigh IM, Thornhill MH. Prevalence and risk factors associated with leukoplakia, hairy leukoplakia, erythematous candidiasis, and gingival hyperplasia in renal transplant recipients. Oral Surg Oral Med Oral Pathol 1994;78:718-726.
12. Bustos DA, Grenon MS, Benitez M, deBaccardo G, Pavan JV, Gendelman H. Human papillomavirus infection in cyclosporin-induced gingival overgrowth in renal allograft recipients. J Periodontol 2001;72:741-744.
13. Saglam F, Onan U, Soydinc M, Yilmaz O, Kirac K, Sever MS. Human papillomavirus in a patient with severe gingival overgrowth associated with cyclosporin therapy. A case report. J Periodontol 1996;67:528-531.
14. Rudlinger R, Smith IW, Bunney MH, Hunter JA. Human papillomavirus infections in a group of renal transplant recipients. Br J Dermatol 1986;115:681-692.
15. Euvrard S, Kanitakis J, Chardonnet Y, Noble CP, Touraine JL, Favre M, Thivolet J, Claudy A. External anogenital lesions in organ transplant recipients. A clinico-pathologic and virologic assessment. Arch Dermatol 1997;133:175-178.
16. Wahlstrom E, Zamora JU, Teichman S. Improvement in cyclosporine- associated gingival hyperplasia with azithromycin therapy. N Engl J Med 1995;332:753-754.
17. Cecchin E, Zanello F, De Marchi S. Treatment of cyclosporine-induced gingival hypertrophy. Ann Intern Med 1997;126:409-410.
18. Meraw SJ, Sheridan PJ. Medically induced gingival hyperplasia [Letter]. Mayo Clin Proc 1999;74:742-743.
19. Bader G, Lejeune S, Messner M. Reduction of cyclosporine-induced gingival overgrowth following a change to tacrolimus. A case history involving a liver transplant patient. J Periodontol 1998;69:729-732.
20. Hernandez G, Arriba L, Lucas M, deAndres A. Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus. J Periodontol 2000;71:1630-1636.
21. Somacarrera ML, Lucas M, Acero J. Reversion of gingival hyperplasia in a heart transplant patient upon interruption of cyclosporine therapy. Spec Care Dentist 1996;16:18-21.
22. Rateitschak-Pluss EM, Hefti A, Lortscher, R, Thiel G. Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Periodontol 1983;10:237-246.
23. Daley TD, Wysocki GP, Day C. Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1986;62:417-421.
24. Barak S, Engelberg IS, Hiss J. Gingival hyperplasia caused by nifedipine. Histopathologic findings. J Periodontol 1987;58:639-642.
25. Slavin J, Taylor J. Cyclosporin, nifedipine and gingival hyperplasia. Lancet 1987;2:739.
26. Meraw SJ, Sheridan PJ. Medically induced gingival hyperplasia. Mayo Clin Proc 1998; 73:1196-1199.